Journal of Biological Chemistry · 2011 · 146 citations · 36 references
Life SciencesCell BiologyMolecular BiologyCell AdhesionCell SignalingSignal TransductionAngiogenesisEndothelial ActivationExtracellular MatrixGrowth Factor SignalingReceptor Tyrosine Kinase SignalingEndothelial Cell MigrationEndothelial MigrationExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingVascular Endothelial Growth Factor
Angiogenesis is required for bone development, growth, and repair. It is influenced by the local bone environment that involves cross-talks between endothelial cells and adjacent bone cells. However, data regarding factors that directly contribute to angiogenesis by bone cells remain poorly understood. Here, we report that EGFL6, a member of the epidermal growth factor (EGF) repeat superfamily proteins, induces angiogenesis by a paracrine mechanism in which EGFL6 is expressed in osteoblastic-like cells but promotes migration and angiogenesis of endothelial cells. Co-immunoprecipitation assays revealed that EGFL6 is secreted in culture medium as a homodimer protein. Using scratch wound healing and transwell assays, we found that conditioned medium containing EGFL6 potentiates SVEC (a simian virus 40-transformed mouse microvascular endothelial cell line) endothelial cell migration. In addition, EGFL6 promotes the endothelial cell tube-like structure formation in Matrigel assays and angiogenesis in a chick embryo chorioallantoic membrane. Furthermore, we show that EGFL6 recombinant protein induces phosphorylation of ERK in SVEC endothelial cells. Inhibition of ERK impaired EGFL6-induced ERK activation and endothelial cell migration. Together, these results demonstrate, for the first time, that osteoblastic-like cells express EGFL6 that is capable of promoting endothelial cell migration and angiogenesis via ERK activation. Thus, the EGLF6 mediates a paracrine mechanism of cross-talk between vascular endothelial cells and osteoblasts and might offer an important new target for the potential treatment of bone diseases, including osteonecrosis, osteoporosis, and fracture healing.
36
Mariella F. Carlevaro, Silvia Cermelli, Ranieri Cancedda et al. · Journal of Cell Science · 2000 · 407 citations
Patricia Collin‐Osdoby, Linda Rothe, Fred Anderson et al. · Journal of Biological Chemistry · 2001 · 400 citations · Full text
The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation
Leon Parker, Maike Schmidt, Suk‐Won Jin et al. · Nature · 2004 · 374 citations